ambrisentan (letairis) Report issue

Small molecule Orphan Drug FDA Approved FDA Priority Review FDA
Back

Drug Pricing Summary

AUS PBS

$47.6691

VA FSS

$94.2020 - $207.7780

VA Big4

$179.0090 - $207.7780

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
ambrisentan 10 mg (TABLET) $47.6691 AUS PBS generic
  • Cipla Ambrisentan (30)
  • Cipla Australia Pty Ltd
  • Ambrisentan Mylan (30)
  • Alphapharm Pty Ltd
  • PULMORIS (30)
  • Cipla Australia Pty Ltd
  • Volibris (30)
  • Seekwell Pty Ltd
    ambrisentan 10 mg (TABLET) $94.2020 VA FSS
  • AMBRISENTAN (30)
  • AvKare, LLC
    ambrisentan 10 mg (TABLET) $191.7953 VA Big4
  • Letairis (30)
  • Gilead Sciences, Inc.
    ambrisentan 10 mg (TABLET) $191.7953 VA FSS
  • Letairis (30)
  • Gilead Sciences, Inc.
    ambrisentan 10 mg (TABLET) $207.7780 VA Big4
  • Letairis (10)
  • Gilead Sciences, Inc.
    ambrisentan 10 mg (TABLET) $207.7780 VA FSS
  • Letairis (10)
  • Gilead Sciences, Inc.
    ambrisentan 5 mg (TABLET) $47.6691 AUS PBS generic
  • Cipla Ambrisentan (30)
  • Cipla Australia Pty Ltd
  • Ambrisentan Mylan (30)
  • Alphapharm Pty Ltd
  • PULMORIS (30)
  • Cipla Australia Pty Ltd
  • Volibris (30)
  • Seekwell Pty Ltd
    ambrisentan 5 mg (TABLET) $94.2020 VA FSS
  • AMBRISENTAN (30)
  • AvKare, LLC
    ambrisentan 5 mg (TABLET) $179.0090 VA Big4
  • Letairis (30)
  • Gilead Sciences, Inc.
    ambrisentan 5 mg (TABLET) $179.0090 VA FSS
  • Letairis (30)
  • Gilead Sciences, Inc.
    ambrisentan 5 mg (TABLET) $207.7780 VA Big4
  • Letairis (10)
  • Gilead Sciences, Inc.
    ambrisentan 5 mg (TABLET) $207.7780 VA FSS
  • Letairis (10)
  • Gilead Sciences, Inc.

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue